Table 3 Logistic Regression Analysis of Independent Predictors of Symptoms Recurrence after one month of discontinuation of Treatment
From: Overactive bladder symptoms recurrence after sudden versus gradual weaning of Solifenacin
ß | P-Value | OR | 95% C.I. for OR | ||
|---|---|---|---|---|---|
Lower | Upper | ||||
Constant | 12.572 | ||||
Age (years) | 0.108 | 0.045* | 1.114 | 0.947 | 1.312 |
OABSS at the baseline (before treatment) | 2.134 | 0.025* | 0.118 | 0.018 | 0.767 |
OABSS 1 month after treatment | − 1.680 | 0.068 | 0.186 | 0.017 | 2.028 |
Treatment protocol | |||||
Group I (sudden stopping) | 3.962 | 0.014* | 52.545 | 1.122 | 2460.225 |
Group II (gradual weaning) | REF | ||||
Model χ2 = 31.578; P- value ≤ 0.001 correctly predicted (38.3%) | |||||